Form 10-Q · Quarterly report
Philip Morris International 10-Q, filed Jul 24, 2026
- Filed
- CIK
- 0001413329
- Accession no.
- 0001628280-26-049493
Summary
Philip Morris International reported net revenues of $21.3 billion for the six months ended June 30, 2026, up 9.8%, while diluted EPS fell 8.4% to $3.36, with the second-quarter EPS decline driven in part by a $511 million non-cash impairment on its RBH equity investment. The filing also detailed an $18 million favorable Egypt sales tax settlement adjustment and restructuring charges tied to U.S. footprint optimization.
Key points
- Net revenues for the six months ended June 30, 2026 were $21.3 billion, up 9.8% from the comparable 2025 period.
- Diluted EPS fell 8.4% to $3.36 for the six months and 7.7% to $1.80 for the second quarter.
- PMI recorded a $511 million non-cash impairment on its RBH equity investment in the second quarter of 2026.
- PMI recorded an $18 million favorable sales tax settlement adjustment after an Egyptian court approved a settlement for the 2016 tax year.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. MANAGEMENT’S DISCUSSION Executive Summary The following executive summary provides the business update and significant highlights from the "Discussion and Analysis" that follows. Consolidated Operating Results for the Six Months Ended June 30, 2026 •Net Revenues - Net revenues of $21.3 billion for the six months ended June 30, 2026, increased by $1.9 billion, or 9.8%, from the comparable 2025 amount. The change in our net revenues from the comparable 2025 amount was driven by the following (variances not to scale with year-to-date results): For the six months ended June 30, 2026, net revenues increased by 9.8%. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.